azenta.com Storage, Automation, & Logistics COVID Vaccine Discovery and Cold Chain Distribution Requirement: Process Control WHITE PAPERStorage, Automation, & Logistics | White Paper Azenta Life Sciences 2 In the wave of COVID research and distribution, can the current cold chain infrastructure support what is coming? In a word: Yes. But only if scalable, consistent, repeatable, and documented processes are in place and ready to go. According to FasterCures, a center of the Milken Institute 1 , the COVID-19 Treatment and Vaccine Tracker cites 315 treatments and 202 vaccines currently in development. Industry’s leading programs are being retooled based on the changes that COVID -19 brings to the industry. New focus areas include topics like supply chain strengthening, growth bioproce

Join for free to read